Plasma Wnt7b protein in rheumatoid arthritis: Detection of interstitial lung disease

Mona Rabie; Hanaa I Abd El-Hady; Dalia A Ibrahim; Tarek H Hassan; Enas I Abdelhady

doi:10.1016/j.imbio.2023.152397

Plasma Wnt7b protein in rheumatoid arthritis: Detection of interstitial lung disease

Immunobiology. 2023 Jul;228(4):152397. doi: 10.1016/j.imbio.2023.152397. Epub 2023 May 29.

Authors

Mona Rabie¹, Hanaa I Abd El-Hady², Dalia A Ibrahim³, Tarek H Hassan³, Enas I Abdelhady⁴

Affiliations

¹ Rheumatology & Rehabilitation Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Electronic address: MRMustafa@medicine.zu.edu.eg.
² Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
³ Chest Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
⁴ Rheumatology & Rehabilitation Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

PMID: 37290224
DOI: 10.1016/j.imbio.2023.152397

Abstract

Objective: To determine the plasma level of Wingless-related integration site 7b (Wnt7b) protein in rheumatoid arthritis (RA) patients (with and without interstitial lung disease (ILD)) and in idiopathic pulmonary fibrosis (IPF) patients and its relationship with RA disease activity and/or severity of pulmonary fibrosis. To assess the validity of plasma Wnt7b for the detection of ILD among RA patients.

Method: This case-control study included 128 subjects (32 RA-ILD, 32 RA, 32 IPF, and 32 healthy controls). RA and RA-ILD Patients were evaluated for disease activity by DAS28 and disease activity grades were recorded according to DAS28 grades. Laboratory parameters as Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Rheumatoid Factor (RF), Anti-citrullinated peptide (Anti-CCP) were recorded. Plasma Wnt7b levels were measured by ELISA. Diagnosis of pulmonary fibrosis (for RA-ILD and IPF patients) was done by high resolution computed tomography (HRCT) and its severity was assessed mainly by pulmonary function test using forced vital capacity (FVC) grading.

Results: Comparison of Wnt7b plasma levels showed a significant difference between the studied groups with the P-value < 0.018 (RA-ILD had the highest levels). Post hoc analysis revealed a significant difference in Wnt7b plasma levels between RA-ILD and IPF groups (P = 0.008). Also, RA-ILD and control groups had a significant difference (P = 0.039). However, there was a non-significant relationship between Wnt7b plasma levels and RA disease activity as well as the severity of pulmonary fibrosis. ROC curve analysis for the plasma Wnt7b levels revealed that a level ≥285.1 pg/ml had a sensitivity of 87.5% and a specificity of 43.8% for the detection of ILD in RA patients with positive likelihood ratio of 1.56 and negative likelihood ratio of 0.29.

Conclusion: RA-ILD patients had significantly higher plasma Wnt7b levels than the controls and IPF patients. These data suggest that the Wnt7b secretion is augmented by the concomitant presence of RA with pulmonary fibrosis. In addition, plasma Wnt7b may be used as a highly sensitive test for the detection of immunologically induced fibrotic changes in lung tissue among RA patients.

Keywords: Idiopathic pulmonary fibrosis (IPF); RA-interstitial lung disease (RA-ILD); Rheumatoid arthritis (RA); Wnt7b.

MeSH terms

Arthritis, Rheumatoid*
Blood Proteins
Case-Control Studies
Humans
Idiopathic Pulmonary Fibrosis* / diagnosis
Lung
Lung Diseases, Interstitial* / diagnosis

Substances

Blood Proteins